ADMA Biologics, Inc. Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

9 Months Ended

Sep. 30, 2021

6.	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities at September 30, 2021 and December 31, 2020 are as follows:

	September 30, 2021		December 31, 2020
Accrued rebates	$	4,507,995	$	2,604,245
Accrued distribution fees		1,981,281		828,120
Accrued payroll		1,763,546		734,972
Accrued testing		1,259,871		779,660
Accrued incentives		2,391,630		3,210,884
Accrued severance		624,522		-
Other		1,881,484		207,262
Total accrued expenses and other current liabilities	$	14,410,329	$	8,365,143